Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury Due to Amoxicillin-Clavulanate
Authors:
- 7 December 2022
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 164 (3) , 454-466
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (U01-DK065201)
- National Institute of Diabetes and Digestive and Kidney Diseases (U01-DK083023)
- National Institute of Diabetes and Digestive and Kidney Diseases (U01-DK065211)
- National Institute of Diabetes and Digestive and Kidney Diseases (U01-DK082992)
- National Institute of Diabetes and Digestive and Kidney Diseases (U01-DK065184)
- National Institute of Diabetes and Digestive and Kidney Diseases (U01DK065193)
- National Institute of Diabetes and Digestive and Kidney Diseases (U01-DK065176)
- Johns Hopkins University (UOIHG004599)
- Johns Hopkins University (U01HG004424)
- Instituto de Salud Carlos III
- University of Nottingham
- Duke University (U01-DK065201)
- Indiana University (U01DK065193)
- National Institutes of Health (R01 MH084098)
- National Institutes of Health (RC2MH089964)
- National Institutes of Health (U01HG007417)
- University of North Carolina Wilmington (U01-DK065184)
- European Cooperation in Science and Technology (BRC-1215-20003)
- European Cooperation in Science and Technology (CA17112)
- National Human Genome Research Institute (U01HG004438)
- National Human Genome Research Institute (U01AG006781)
- National Eye Institute
- Vanderbilt University
- National Center for Advancing Translational Sciences
- University of Connecticut
- European Regional Development Fund (FIS PI16_01748)
- European Regional Development Fund (PI15 _01440)
- Broad Institute (RC2MH089964)
- Broad Institute (R01 MH084098)
- Broad Institute (U01HG007417)
- Broad Institute (U01HG004608)
- Broad Institute (U01HG04603)
- Broad Institute (U01HG004603)
- National Cancer Institute (U01CA155309)
- Hebrew University of Jerusalem
- Icahn School of Medicine at Mount Sinai
- Mayo Clinic
- University of Texas Southwestern Medical Center
- University of Southern California
- National Institute for Health and Care Research
- University of Michigan (U01-DK065211)
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas
- Agencia Española de Medicamentos y Productos Sanitarios
This publication has 36 references indexed in Scilit:
- HLA Alleles Influence the Clinical Signature of Amoxicillin-Clavulanate HepatotoxicityPLOS ONE, 2013
- HIBAG—HLA genotype imputation with attribute baggingThe Pharmacogenomics Journal, 2013
- Black Patients of African Descent and HLA-DRB1*15:03 Frequency Overrepresented in Epidermolysis Bullosa AcquisitaJournal of Investigative Dermatology, 2011
- Susceptibility to Amoxicillin-Clavulanate-Induced Liver Injury Is Influenced by Multiple HLA Class I and II AllelesGastroenterology, 2011
- Balancing Selection Maintains a Form of ERAP2 that Undergoes Nonsense-Mediated Decay and Affects Antigen PresentationPLOS Genetics, 2010
- Drug-Induced Acute Liver FailureHepatology, 2010
- LocusZoom: regional visualization of genome-wide association scan resultsBioinformatics, 2010
- Detecting gene–gene interactions that underlie human diseasesNature Reviews Genetics, 2009
- PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage AnalysesThe American Journal of Human Genetics, 2007
- Determinants of the clinical expression of amoxicillin‐clavulanate hepatotoxicityHepatology, 2006